Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Morison

Showing results (41-50 of 114) with videos related to

Pageof 12
Sort By:
Journal of Clinical Immunology|August 6, 2021
Aberrant Immunoglobulin Kappa Locus Rearrangement in a Patient with CARD11-Related B Cell LymphocytosisJackie L Ludgate, Robert J Weeks, Ian M Morison
Journal of Medical Case Reports|May 11, 2018
Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case reportKern Y Chai, Anna L Byrne, Ian M Morison
Journal of Wound Care|February 1, 1996
The management of leg ulcersE A Nelson, C V Ruckley, J Dale, et al.
Medicine|April 11, 2015
Identification of X monosomy cells from a gonad of mixed gonadal dysgenesis with a 46,XY karyotype: case reportNoriko Nishina-Uchida, Ryuji Fukuzawa, Yukihiro Hasegawa, et al.
Journal of the National Cancer Institute|December 5, 2002
Re: Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumorIan M Morison, David M O Becroft, Anthony E Reeve
British Journal of Urology|February 1, 1992
A prostatectomy audit: phase I--insights and questionsG B McKelvie, M Morison, M Hehir, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1997
Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesisK Okamoto, I M Morison, T Taniguchi, et al.
Pathology|September 1, 2019
Haematologists usually over-estimate the percentage of CD138+ plasma cells in marrow biopsiesKern Y Chai, Arvenia A Boyke Berahmana, Ian M Morison
Molecular Cancer|June 25, 2010
Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemiaRobert J Weeks, Ursula R Kees, Sarah Song, et al.
Seminars in Thrombosis and Hemostasis|November 22, 2011
Congenital thrombocytopenia and cytochrome C mutation: a matter of birth and deathElisabeth Cramer Bordé, Yasmine Ouzegdouh, Elizabeth C Ledgerwood, et al.
Pageof 12

Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Journal of Clinical Immunology|August 6, 2021
Aberrant Immunoglobulin Kappa Locus Rearrangement in a Patient with CARD11-Related B Cell LymphocytosisJackie L Ludgate, Robert J Weeks, Ian M Morison
Journal of Medical Case Reports|May 11, 2018
Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case reportKern Y Chai, Anna L Byrne, Ian M Morison
Journal of Wound Care|February 1, 1996
The management of leg ulcersE A Nelson, C V Ruckley, J Dale, et al.
Medicine|April 11, 2015
Identification of X monosomy cells from a gonad of mixed gonadal dysgenesis with a 46,XY karyotype: case reportNoriko Nishina-Uchida, Ryuji Fukuzawa, Yukihiro Hasegawa, et al.
Journal of the National Cancer Institute|December 5, 2002
Re: Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumorIan M Morison, David M O Becroft, Anthony E Reeve
British Journal of Urology|February 1, 1992
A prostatectomy audit: phase I--insights and questionsG B McKelvie, M Morison, M Hehir, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1997
Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesisK Okamoto, I M Morison, T Taniguchi, et al.
Pathology|September 1, 2019
Haematologists usually over-estimate the percentage of CD138+ plasma cells in marrow biopsiesKern Y Chai, Arvenia A Boyke Berahmana, Ian M Morison
Molecular Cancer|June 25, 2010
Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemiaRobert J Weeks, Ursula R Kees, Sarah Song, et al.
Seminars in Thrombosis and Hemostasis|November 22, 2011
Congenital thrombocytopenia and cytochrome C mutation: a matter of birth and deathElisabeth Cramer Bordé, Yasmine Ouzegdouh, Elizabeth C Ledgerwood, et al.
Pageof 12